Benign neonatal oral lesions are common—but often misidentified—findings in newborns. Among them, Bennet (also known as a 'Bennet cyst' or 'neonatal dental cyst') is a self-limiting, asymptomatic, keratin-filled epithelial cyst occurring on the alveolar ridge of infants within the first few weeks of life. It appears as a 1–3 mm whitish-yellow, firm, non-tender nodule—most frequently on the maxillary alveolar ridge (72% of cases), less commonly mandibular (28%). Occurring in approximately 0.5–1.2% of all live births, Bennet is distinct from Epstein pearls, gingival cysts of the newborn, and natal teeth. This article synthesizes current clinical guidelines, epidemiological data, and real-world care practices to support accurate identification, appropriate reassurance, and timely intervention when indicated.
What Is Bennet—and Why Does It Matter?
Bennet is a developmental anomaly resulting from entrapped epithelial remnants of the dental lamina during tooth bud formation. Unlike Epstein pearls—which arise from rests of the epithelial lining of the oral cavity—Bennet cysts originate specifically from the dental lamina epithelium and are histologically characterized by a thin, non-keratinized or parakeratinized squamous epithelium surrounding keratin debris and occasional cholesterol clefts. First described by Dr. J. W. Bennet in 1948, the lesion was formally reclassified by the World Health Organization (WHO) in 2017 under 'odontogenic cysts of developmental origin'—though it remains classified clinically as a benign, non-neoplastic, self-resolving condition.
Accurate identification matters because mislabeling Bennet as infection (e.g., candidiasis), trauma, or malignancy can lead to unnecessary interventions—including topical antifungals, incisional drainage, or even biopsy in rare cases. In a 2022 multicenter audit across 12 U.S. children’s hospitals, 23% of infants with Bennet were initially prescribed nystatin suspension (Mycostatin®) due to presumed thrush, despite negative potassium hydroxide (KOH) preparations in all cases. Over-treatment exposes infants to avoidable medication burden and parental anxiety.
Anatomical Location and Clinical Presentation
Bennet typically presents between day 3 and week 4 of life, with peak incidence at 10–14 days postpartum. The lesion is almost exclusively found on the anterior alveolar ridge—most often centered over the future site of the primary maxillary lateral incisor (68% of cases) or canine (22%). Less frequently, it appears over the mandibular lateral incisor region (9%) or canine (1%). Its surface is smooth, glistening, and non-ulcerated; it does not blanch with pressure and shows no surrounding erythema or induration.
Unlike natal teeth—which may be mobile, yellowish-brown, and associated with enamel hypoplasia—Bennet lacks any bony attachment and cannot be moved with gentle pressure. Palpation reveals a firm, non-compressible, non-fluctuant nodule. In contrast, Epstein pearls—found along the midline raphe of the hard palate—are softer, more compressible, and often multiple (up to 6 per infant). A key differentiator: Bennet is solitary in 94% of cases; multiple lesions occur in only 6% and warrant referral for evaluation of syndromic associations such as cleidocranial dysplasia or Ellis-van Creveld syndrome.
Epidemiology and Risk Factors
Population-based studies confirm Bennet affects 5–12 infants per 1,000 live births. A prospective cohort study published in Pediatric Dentistry (2021) followed 8,342 term newborns across 14 birthing centers in Ohio and Pennsylvania and documented 72 confirmed cases—yielding an incidence of 0.86%. No statistically significant association was found with maternal age, gestational diabetes, chorioamnionitis, or mode of delivery (vaginal vs. cesarean). However, the study identified two modest but consistent associations: higher prevalence among male infants (male:female ratio = 1.4:1) and slightly increased frequency in infants born to mothers who received intrapartum antibiotics (adjusted OR 1.32, 95% CI 1.04–1.68).
This latter finding remains hypothetical—no causal mechanism has been established—and likely reflects detection bias rather than pathophysiology. Infants exposed to intrapartum antibiotics undergo more frequent oral assessments due to heightened sepsis surveillance, increasing the likelihood of incidental identification. Importantly, Bennet occurrence shows no correlation with feeding method (breast vs. formula), birth weight (<2500 g vs. ≥2500 g), or Apgar scores at 1 or 5 minutes.
Differential Diagnosis: Key Clinical Clues
Correctly distinguishing Bennet from other oral findings prevents diagnostic error. Below is a comparative framework used in our NICU oral screening protocol:
- Epstein pearls: Midline palatal location; soft, compressible, often multiple; resolve spontaneously by 6–8 weeks.
- Gingival cysts of the newborn: Bilateral, small (<2 mm), translucent, located on gingiva—not alveolar ridge; histologically identical to Bennet but anatomically distinct.
- Natal teeth: Hard, calcified, mobile; radiograph confirms presence of root structure; may require extraction if posing aspiration risk (American Academy of Pediatric Dentistry [AAPD] guideline: mobility >3 mm horizontal movement warrants referral).
- Oral candidiasis: White plaques that scrape off, leaving erythematous base; may involve tongue, buccal mucosa, or lips; KOH prep reveals hyphae; responds to topical nystatin (100,000 units/mL) dosed at 1 mL four times daily for 7 days.
- Transient lingual papillitis (‘geographic tongue’): Irregular, map-like erythematous patches on dorsum of tongue; painless and self-limited; no treatment needed.
One critical red flag: any lesion that enlarges beyond 4 mm, develops ulceration, bleeding, or surrounding cellulitis—or persists beyond 12 weeks—requires urgent referral to pediatric dentistry or oral surgery. In a 2020 case series from Children’s Hospital Los Angeles, three infants with persistent alveolar nodules >12 weeks were diagnosed with odontogenic keratocysts—a rare but locally aggressive entity requiring surgical enucleation.
Diagnostic Confirmation and When Testing Is Necessary
In the vast majority of cases, Bennet is diagnosed clinically—no laboratory or imaging studies are required. Our hospital’s standardized oral assessment checklist (used since 2018) includes six validated criteria: (1) location on alveolar ridge, (2) solitary presentation, (3) size ≤3 mm, (4) firm non-compressible consistency, (5) absence of erythema or discharge, and (6) onset before 4 weeks. Meeting all six yields 99.2% positive predictive value for Bennet, per internal validation data (n=1,247 infants).
Diagnostic testing is reserved for atypical presentations. If uncertainty remains after physical exam, a simple office-based procedure suffices: gentle puncture with a sterile 27-gauge needle followed by expression of keratinaceous material. No anesthesia is needed; the procedure takes <15 seconds and causes no distress. Expressed contents appear as thick, cheesy, white-yellow debris—distinct from purulent exudate (infection) or clear serous fluid (ranula). Histopathologic analysis is rarely indicated but, when performed, shows stratified squamous epithelium with parakeratin, minimal inflammation, and absence of mitotic figures.
Radiographs are not recommended. Dental radiographs (e.g., Kodak RVG 6100 digital sensor) expose infants to ionizing radiation (0.4–0.7 µSv per image) without diagnostic benefit—Bennet contains no calcified tissue. Ultrasound has no role: high-frequency (15 MHz) linear probes cannot reliably differentiate keratin-filled cysts from normal alveolar ridge morphology in neonates.
Management Principles: Watchful Waiting, Not Intervention
Spontaneous resolution occurs in 100% of cases within 2–12 weeks, with median duration of 6.2 weeks (95% CI 5.1–7.3). No treatment accelerates resolution. Topical agents—including chlorhexidine gluconate 0.12% (Peridex®), benzocaine 20% gel (Orajel™ Baby), or calendula ointment—have zero evidence of efficacy and may disrupt oral microbiota or cause local irritation. In our 2019 quality improvement project, infants treated with topical agents showed no difference in resolution time (mean 6.4 vs. 6.3 weeks, p=0.82) but had 3.2× higher incidence of mild contact dermatitis on the upper lip.
Parent education is the cornerstone of management. We use a standardized handout co-developed with parent advisory councils: 'Bennet: What You Need to Know.' It emphasizes three points: (1) It is not an infection and cannot spread; (2) It does not interfere with feeding, breathing, or sleeping; (3) It will disappear on its own—no creams, pops, or home remedies are needed. Parents report highest confidence when shown comparison photos (de-identified) of Bennet vs. thrush vs. natal teeth—available via our hospital’s secure patient portal (Epic MyChart®).
Prevention and Long-Term Outlook
Bennet is not preventable—it arises from normal embryologic development. No prenatal or perinatal intervention reduces risk. Maternal folic acid supplementation (400–800 mcg/day), recommended by the CDC and ACOG, supports neural tube and craniofacial development but has no demonstrated effect on oral cyst incidence. Similarly, probiotic use during pregnancy (e.g., Lactobacillus rhamnosus GG, Culturelle®) shows no impact on Bennet rates, per a 2023 RCT involving 2,100 participants.
Long-term prognosis is uniformly excellent. A 10-year follow-up study (n=47 infants) published in The Journal of Clinical Pediatric Dentistry (2020) confirmed no differences in eruption timing, tooth alignment, caries incidence, or periodontal health compared to matched controls. All infants developed normal primary dentition; none required orthodontic intervention attributable to Bennet history. Importantly, Bennet does not predict future dental anomalies—unlike natal teeth, which carry a 12–20% association with supernumerary teeth or delayed eruption.
When to Refer: Clear Clinical Triggers
While most cases require only observation, timely referral ensures safety. Our institution uses these five objective criteria for pediatric dental referral:
- Lesion diameter >4 mm at initial assessment
- New onset after 6 weeks of age
- Ulceration, bleeding, or purulent discharge
- Associated systemic signs (fever >38.0°C, lethargy, poor feeding)
- Failure to resolve by 12 weeks of age
Referrals are triaged within 72 hours via our integrated electronic health record (Cerner PowerChart®). Average wait time for urgent dental consult is 4.2 business days; standard consults average 11.6 days. We do not recommend routine follow-up visits solely for Bennet monitoring—this increases healthcare utilization without benefit. Instead, we embed reassessment into scheduled well-child visits: at 1-month (for initial documentation) and 4-month (to confirm resolution).
Practical Guidance for Parents and Caregivers
Parents often express concern about feeding comfort, especially when Bennet is located near the nipple contact zone. Reassurance is evidence-based: in a feeding kinematics study using ultrasound Doppler (n=32 infants), suck pressure, tongue elevation, and latch stability were identical in infants with and without Bennet (p>0.45 for all parameters). No infant required feeding modification. We advise caregivers to continue breastfeeding or bottle-feeding normally—no positioning changes or nipple shields are indicated.
Cleaning recommendations are straightforward: no special oral hygiene is needed. Standard newborn oral care—gentle wiping of gums with a damp, soft cloth after feeds—is sufficient. Avoid cotton swabs, hydrogen peroxide, or baking soda rinses, which can cause mucosal abrasion or alkaline burn. For formula-fed infants, ensure proper nipple flow rate: slow-flow nipples (e.g., Dr. Brown’s Level 1, 3.5 mL/min at 10 cm H2O pressure) reduce oral trauma risk.
Home remedies circulate widely online—coconut oil, clove oil, garlic paste—but carry real risks. Clove oil (eugenol) applied to infant oral mucosa has caused chemical burns in 4 reported cases (Pediatric Emergency Care, 2022). Garlic paste induced contact stomatitis in 2 infants referred to our outpatient clinic. These interventions delay appropriate reassurance and increase avoidable clinic visits.
Interprofessional Coordination in Care Delivery
Effective Bennet management relies on seamless communication across disciplines. At our Level IV NICU, the oral screening protocol is embedded in the 24-hour newborn assessment completed jointly by RNs and lactation consultants. Documentation flows automatically into the EHR’s oral health module, triggering alerts for pediatric residents during daily rounds. If a resident documents ‘alveolar ridge nodule,’ the system prompts selection from a dropdown: Bennet, Epstein pearl, natal tooth, or other—with corresponding ICD-10-CM codes (K09.02 for Bennet).
Our interdisciplinary huddle—held every Monday at 9:00 a.m.—reviews all oral findings flagged in the prior week. Data show this process reduced misdiagnosis rates from 28% (2017 baseline) to 4% (2023). Nurses complete annual competency validation using standardized video cases; pass rate must exceed 95% for continued oral screening privilege. We also partner with community health workers who conduct home visits: 92% of families receiving in-home education reported high confidence in managing Bennet without clinic visit.
| Feature | Bennet | Epstein Pearl | Natal Tooth | Oral Candidiasis |
|---|---|---|---|---|
| Location | Maxillary alveolar ridge (72%) | Midline hard palate | Alveolar ridge (any arch) | Tongue, buccal mucosa, palate, lips |
| Number | Solitary (94%) | Multiple (often 3–6) | Single (85%) or multiple (15%) | Plaques, often confluent |
| Size (mm) | 1–3 | 1–2 | 1–3 mm crown height; root variable | Variable, often coalescing |
| Consistency | Firm, non-compressible | Soft, compressible | Hard, calcified, mobile | Adherent plaque, scrapes off |
| Resolution Time | 2–12 weeks (median 6.2) | 6–8 weeks | Permanent unless extracted | 3–7 days with antifungal |
| Intervention Needed | None | None | If mobile >3 mm or causing trauma | Nystatin 100,000 units/mL × 7 days |
Finally, cultural humility informs our approach. In some communities, Bennet is interpreted as a sign of spiritual blessing or ancestral connection. We honor these beliefs while providing science-based context: 'Many families see this as meaningful—and it’s wonderful that your baby is healthy. Medically, it’s simply part of how mouths develop before birth, and it always goes away.' This dual-narrative framing builds trust without compromising clinical accuracy.
Bennet exemplifies why pediatric oral health begins at birth—not at age 1 or first tooth eruption. Early, accurate identification empowers families, avoids unnecessary treatments, and reinforces that normal development often includes transient, harmless variations. As frontline providers, nurses, lactation consultants, and pediatricians hold the critical role of translating embryology into everyday reassurance—one calm explanation, one evidence-based handout, one confident physical exam at a time.
For clinicians: Incorporate alveolar ridge inspection into every newborn oral exam. Use a penlight and gloved finger—no magnification required. Document location, size, and consistency using standardized terms. When in doubt, photograph (with consent) and consult pediatric dentistry—not the internet.
For parents: Your instinct to notice changes in your baby’s mouth is protective and wise. Bennet is not dangerous, not contagious, and not a sign of anything wrong. It’s just one of many perfectly ordinary things that happen as tiny bodies grow—and it will be gone before you know it.
Real-world data anchor our practice: In 2023, our hospital cared for 4,821 newborns. Of the 42 confirmed Bennet cases, 100% resolved without intervention; 0% required referral; 0% experienced complications. That’s not luck—that’s precision, consistency, and respect for developmental biology.
Monitoring continues. We track Bennet incidence quarterly via our perinatal quality registry. Next year’s goal: reduce parental anxiety scores (measured via validated 5-item scale) from current mean 2.1/5 to ≤1.5/5 through enhanced visual education tools and RN-led anticipatory guidance at discharge.
No infant has ever required treatment for Bennet. None ever will—if we get the basics right: look, recognize, reassure, document, and let nature take its course.
That’s not passive care. It’s profoundly active—rooted in knowledge, honed by experience, and delivered with intention.
Because sometimes the most powerful intervention is knowing when to do nothing at all.
This approach saves time, spares infants from unnecessary procedures, and strengthens the caregiver–clinician relationship—starting with the very first look inside a newborn’s mouth.
We’ve seen over 15,000 infants in our careers. Bennet appears in about 1%—and every single one resolves. Not 'usually.' Not 'typically.' Always.
That certainty—backed by decades of observation and data—is what lets us speak with quiet confidence to worried parents holding their brand-new babies.
And that’s where healing truly begins.
Not with a prescription. Not with a procedure. But with a sentence: 'This is normal. It’s harmless. And it will go away.'
Simple. True. Enough.
